DERM · Journey Medical Corp
United States · RS rating 19 · As of 2026-11-03
| Price | 4.64 USD |
|---|---|
| 1-day change | -3.1% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 12 / 23 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 5 / 53 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +87.5% |
| Sales growth Q/Q | -8.8% |
| Distance from 52-week high | +49.9% |
| Market cap (USD) | $170.6M |